Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 5/2024

Open Access 01-05-2024 | Research

Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma

Authors: Yijia He, Lingyun Liu, Yuexin Dong, Xiaoxin Zhang, Yuxian Song, Yue Jing, Yanhong Ni, Yi Wang, Zhiyong Wang, Liang Ding

Published in: Cancer Immunology, Immunotherapy | Issue 5/2024

Login to get access

Abstract

Background

Lipid droplets (LDs) as major lipid storage organelles are recently reported to be innate immune hubs. Perilipin-3 (PLIN3) is indispensable for the formation and accumulation of LDs. Since cancer patients show dysregulated lipid metabolism, we aimed to elaborate the role of LDs-related PLIN3 in oral squamous cell carcinoma (OSCC).

Methods

PLIN3 expression patterns (n = 87), its immune-related landscape (n = 74) and association with B7-H2 (n = 51) were assessed by immunohistochemistry and flow cytometry. Real-time PCR, Western blot, Oil Red O assay, immunofluorescence, migration assay, spheroid-forming assay and flow cytometry were performed for function analysis.

Results

Spotted LDs-like PLIN3 staining was dominantly enriched in tumor cells than other cell types. PLIN3high tumor showed high proliferation index with metastasis potential, accompanied with less CD3+CD8+ T cells in peripheral blood and in situ tissue, conferring immunosuppressive microenvironment and shorter postoperative survival. Consistently, PLIN3 knockdown in tumor cells not only reduced LD deposits and tumor migration, but benefited for CD8+ T cells activation in co-culture system with decreased B7-H2. An OSCC subpopulation harbored PLIN3highB7-H2high tumor showed more T cells exhaustion, rendering higher risk of cancer-related death (95% CI 1.285–6.851).

Conclusions

LDs marker PLIN3 may be a novel immunotherapeutic target in OSCC.
Literature
19.
go back to reference Fujimoto M, Yoshizawa A, Sumiyoshi S, Sonobe M, Menju T, Hirata M, Momose M, Date H, Haga H (2017) Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases. Histopathology 70:232–241. https://doi.org/10.1111/his.13048CrossRefPubMed Fujimoto M, Yoshizawa A, Sumiyoshi S, Sonobe M, Menju T, Hirata M, Momose M, Date H, Haga H (2017) Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases. Histopathology 70:232–241. https://​doi.​org/​10.​1111/​his.​13048CrossRefPubMed
23.
go back to reference Than GN, Turóczy T, Sümegi B, Than NG, Bellyei S, Bohn H, Szekeres G (2001) Overexpression of placental tissue protein 17b/TIP47 in cervical dysplasias and cervical carcinoma. Anticancer Res 21:639–642PubMed Than GN, Turóczy T, Sümegi B, Than NG, Bellyei S, Bohn H, Szekeres G (2001) Overexpression of placental tissue protein 17b/TIP47 in cervical dysplasias and cervical carcinoma. Anticancer Res 21:639–642PubMed
Metadata
Title
Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma
Authors
Yijia He
Lingyun Liu
Yuexin Dong
Xiaoxin Zhang
Yuxian Song
Yue Jing
Yanhong Ni
Yi Wang
Zhiyong Wang
Liang Ding
Publication date
01-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 5/2024
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-024-03659-9

Other articles of this Issue 5/2024

Cancer Immunology, Immunotherapy 5/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine